0.00Open0.05Pre Close0 Volume479 Open Interest10.00Strike Price0.00Turnover9177.39%IV16.18%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-20DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1372Delta0.2947Gamma173.00Leverage Ratio-280.0876Theta0.0000Rho23.73Eff Leverage0.0000Vega
MiMedx Stock Discussion
I want more, pls go down for a minute
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$